GSK China Said Target Of HQ Probe Of Doctor Favors To Prescribe Botox
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline reportedly has an in-house investigation under way into allegations its China sales representatives provided cash and other perks to physicians who prescribed the manufacturer’s Botox and then engaged in a cover-up.